TrialCancer medicine2023

Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III.

Toshimi Takano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.